The three-dimensional structure of the VDR remains unknown as does the exact mechanism by which the VDR interacts with the transcriptional machinery. Experiments with the cloned receptor in transfected cells have shown that the protein can be functionally divided into several domains, including the DNA-binding domain, near the amino terminus, and the ligand-binding domain (LBD), which occupies the carboxy-terminal portion of the protein (4). The LBD of the receptor is the focus of much investigation into how ligand binds to the receptor and how this binding affects receptor conformation. The structures of the LBDs of related receptors (the retinoic acid receptor ␥ (RAR␥), the thyroid hormone receptor ␣ (TR␣), and the retinoic X receptor ␣ (RXR␣)) have been determined (5-7). The structures of these LBDs are similar, suggesting that they can be utilized as models for the LBD of the VDR. However, functional differences exist between the VDR and the other receptors which point to potential structural distinctions. For example, both the retinoid and thyroid hormones are bound by the nuclear receptor corepressor NCoR, which binds to a specific sequence in the LBDs of these proteins termed the CoR box.
The vitamin D receptor (VDR) 7 protein mediates the effects of vitamin D on bone, intestine, and other organs involved in maintenance of calcium homeostasis (1) . This protein binds its ligand, 1,25-dihydroxyvitamin D 3 (1,25-(OH) 2 D 3 ), with very high affinity, with a K d of the order of 10 Ϫ11 M (2). Binding of ligand to the receptor sets in motion a sequence of events that results in modulation of the rate of transcription of target genes (3) .
The three-dimensional structure of the VDR remains unknown as does the exact mechanism by which the VDR interacts with the transcriptional machinery. Experiments with the cloned receptor in transfected cells have shown that the protein can be functionally divided into several domains, including the DNA-binding domain, near the amino terminus, and the ligand-binding domain (LBD), which occupies the carboxy-terminal portion of the protein (4) . The LBD of the receptor is the focus of much investigation into how ligand binds to the receptor and how this binding affects receptor conformation. The structures of the LBDs of related receptors (the retinoic acid receptor ␥ (RAR␥), the thyroid hormone receptor ␣ (TR␣), and the retinoic X receptor ␣ (RXR␣)) have been determined (5) (6) (7) . The structures of these LBDs are similar, suggesting that they can be utilized as models for the LBD of the VDR. However, functional differences exist between the VDR and the other receptors which point to potential structural distinctions. For example, both the retinoid and thyroid hormones are bound by the nuclear receptor corepressor NCoR, which binds to a specific sequence in the LBDs of these proteins termed the CoR box. 7 Abbreviations used: VDR, vitamin D receptor; 1,25-(OH) 2 However, the VDR is not bound by NCoR, despite the presence of a CoR box sequence in the relevant part of the VDR (8) . In addition, a recent report indicates that in order to form a stable heterodimer complex with RXR, the VDR requires a larger portion of the RXR protein than either RAR or TR (9) . Thus, although the overall structural resemblance may be large, there are reasons to believe that the VDR LBD may differ in some key areas from related proteins.
In order to better understand the way in which the receptor protein binds ligand, we have expressed the LBD of the VDR (amino acid 115-423) in a bacteria. Following purification, the LBD was then characterized using a ligand-binding assay, fluorescence and circular dichroism spectroscopy, and by analytical ultracentrifugation. The ligand-binding assay was used to characterize the affinity of the LBD for ligand, to determine whether the protein had the same affinity for ligand as the full-length receptor. Fluorescence spectroscopy provides insight primarily into the environment of the tryptophan residues in a protein, due to their high intrinsic fluorescence, and has been used previously with other receptors as an indicator that the purified protein is homogeneous in its ability to bind ligand. Work with the retinoic acid receptor (10) and the RXR (6, 11) showed near-complete quenching of tryptophan fluorescence following ligand binding to these proteins. The relevance of these observations is also highlighted in the structure of the RAR␥ LBD (6), in which one of the two tryptophan residues was shown to be in close proximity to the ␤-ionone ring of bound retinoid. Postulating that the single tryptophan in the VDR LBD might also play a role in the high-affinity binding to 1,25-(OH) 2 D 3 , we examined the fluorescence properties of the LBD both in the presence and absence of ligand.
The LBDs of the other receptors that have been studied to date exhibited a high content of ␣ helix based on circular dichroism data (10, 11) , and this has been confirmed by X-ray crystallography (5, 6) . The far-UV CD spectrum (200 -250 nm) of the VDR LBD was examined to determine whether it was consistent with the high ␣ helical content observed for these other receptors.
Near-UV CD spectra (250 -300 nm) often exhibit signals arising from the aromatic residues which are sensitive to the detailed electronic environment of these residues (13) . For this reason, the near-UV CD signal of LBD in the presence and absence of its ligand was examined to see if ligand binding altered the environment in the vicinity of the tryptophan residue of the LBD.
With the exception of the RXR, the oligomeric state of the LBDs of other receptors has not been extensively studied. The LBD of the RXR was reported to be either a monomer using equilibrium sedimentation analysis (12) or a dimer using gel filtration and laser light scattering (11) and was crystallized as a dimer (5) . In contrast, the LBDs of both RAR and thyroid hormone receptors crystallized as monomers (6, 7) , although the LBD of the thyroid hormone receptor was shown to migrate over a gel filtration column as a mixture of monomer and dimer (14) . We have examined the VDR LBD by sedimentation equilibrium to determine whether the protein self-associates in solution and to see if addition of ligand to the protein has any effect upon this association.
MATERIALS AND METHODS
Construction of the bacterial expression vector. Construction of the vector for LBD with an N-terminal 6 ϫ His tag was carried out as follows: the StuI-BglII fragment of the rat VDR was excised from the expression vector pCKR3, purified on a 0.8% agarose gel, and eluted using Geneclean (Bio101). The purified DNA fragment was subcloned into the vector pET14B (Novagen, Madison, WI) in which the original BglII site had been disrupted by insertion of an oligonucleotide with BamHI ends and into which a new multiple cloning site had been inserted by subcloning of an annealed duplex oligonucleotide into the BamHI site. This new multiple cloning site was based on that of the vector pGEX-4T-3 and included a BglII site immediately 3Ј of the stop codons. The modified vector was digested with SmaI and BglII and dephosphorylated with calf intestine alkaline phosphatase prior to ligation. Plasmids obtained after transformation of competent JM105 cells and overnight growth were subjected to digestion with BamHI and BglII to confirm the presence of the insert.
Expression of the VDR LBD. Bacteria of the strain BL21(DE3) pLysS (Novagen) were transformed with the LBD expression vector and plated on LB agar plates containing 100 g/ml ampicillin and 30 g/ml chloramphenicol. After overnight growth at 37°C, an isolated colony was used to inoculate 100 ml of LB medium containing 100 g/ml ampicillin and 30 g/ml chloramphenicol. Following overnight growth at 37°C, 10 ml of this culture was used to inoculate 1 liter of LB medium. The cells were grown to an OD 600 of 0.6 at 37°C and then moved to a shaker at 22°C. Protein expression was induced by addition of 0.4 mM isopropyl ␤-D-thiogalactoside and the cells were grown for an additional 3 h before being harvested by centrifugation. The pellets were resuspended in 10 ml/liter of 50 mM sodium phosphate buffer, pH 8.0. Phenylmethylsulfonyl fluoride was added in ethanol to a final concentration of 1 mM, followed by addition of 100 g/ml lysozyme. After incubation at room temperature for 10 min, Tween 20 was added to a final concentration of 1%, and the cell suspensions were frozen in liquid nitrogen.
Purification of the LBD protein. The frozen cell suspensions containing the expressed LBD were thawed at room temperature, placed on ice and subjected to 5-10 bursts of sonication (30 s per burst) using a Branson sonicator equipped with a probe (VWR, Batavia, IL). The cell lysate was centrifuged at 30,000g for 20 min and the supernatant carefully decanted. The supernatant was applied to a column of Ni-NTA agarose (Qiagen, Santa Clarita, CA) and washed with increasing concentrations of imidazole in 50 mM sodium phosphate buffer, pH 7.0. ␤-Mercaptoethanol was added to a final concentration of 5 mM as an antioxidant. Purified LBD protein was eluted with a step gradient of 100 -200 mM imidazole in 50 mM increments. Fractions containing the purified protein were pooled and dialyzed against 50 mM sodium phosphate buffer to remove imidazole and then further purified on a MonoS HiTrap column (Pharmacia, Piscataway, NJ) and eluted using increasing concentrations of sodium chloride from 50 to 500 mM. Purified protein fractions were pooled, dialyzed against the buffer to be used in experiments (50 mM Hepes, 43 LIGAND-BINDING DOMAIN OF THE VITAMIN D RECEPTOR pH 7.5 containing 100 mM NaCl), concentrated, and drop-frozen in liquid nitrogen.
Measurement of ligand-binding affinity. The ligand-binding affinity of the LBD was measured by a modification of the hydroxylapatite (HAP) assay. The purified LBD protein was serially diluted in 50 mM Tris-HCl, pH 7.5, containing 150 mM KCl, 100 g/ml purified bovine serum albumin, 1% CHAPS, and 5 mM DTT. Increasing concentrations of tritiated 1,25-(OH) 2 D 3 (160 Ci/mmol) were added to the protein, and after incubation on ice for 16 h, HAP resin (Bio-Rad, Hercules, CA) was added to bind the LBD protein and any associated ligand. This was followed by extensive washing with 50 mM Tris/1.5 mM EDTA/0.5% Triton X-100 to remove free ligand. The amount of bound ligand was quantitated by scintillation counting. Binding curves were analyzed using the program BIOEQS (15) (16) (17) . This program uses a numerically based constrained optimization and thus does not require a closed-form analytical expression for the binding isotherm (18) . The model used assumed ligand binding to monomeric species only and included as species free monomeric receptor, free ligand, and receptor bound ligand. BIOEQS solves the system of free energy equations for this model with the constraints of mass conservation for both protein subunits and ligand in terms of the species concentration vector. Best fit values of the free energy parameters are in turn obtained using a Marquardt-Levenberg nonlinear least squares algorithm.
Measurement of tryptophan fluorescence. All fluorescence measurements were carried out using protein concentrations between 1.0 and 5.0 M in a buffer containing the following molecular biology grade reagents (Research Organics, Inc., Cleveland, OH): 250.0 mM Tris, 1.0 mM EDTA, 15% glycerol (spectroscopic grade; Aldrich, Milwaukee, WI), 5.0 mM DTT, and 100 mM NaCl at pH 7.6 (TEGD100).
Steady-state fluorescence emission spectra were performed using an ISS Koala automated spectral acquisition unit (ISS, Inc., Champaign, IL) with excitation from a xenon arc lamp and the excitation monochromator set at 295 nm. The excitation and emission band widths were 8 nm.
Time-resolved measurements were performed in the frequency domain using ISS frequency domain acquisition electronics. The excitation light was at 295 nm from the frequency doubled output of a coherent cavity dumped, R6G, picosecond, 701 dye laser (Coherent Corp., Palo Alto, CA) excited with the 532 line of a coherent frequency doubled mode-locked ND-YAG Antares laser (Coherent Corp.) The reference lifetime compound was paraterphenyl with a lifetime of 1.0 ns in cyclohexane (19) .
Data were analyzed with the global analysis software developed by Beechem and coworkers (20) , Globals Unlimited (LFD, Urbana, IL).
Sedimentation equilibrium studies. Sedimentation equilibrium experiments were conducted in a Beckman XL-A analytical ultracentrifuge. To reduce interference from the absorbance of oxidized DTT at 280 nm, the purified protein was dialyzed into fresh experimental buffer (50 mM Hepes/100 mM NaCl/0.1 mM DTT, pH 7.5). Samples with varying initial concentrations (0.6 to 2 mg/ml) were run at 4°C at several rotor speeds in an An60 rotor. Equilibrium was verified by comparing gradients approximately 2 h apart until no further change in the profile was observed. The presence of nonsedimenting absorbance was determined by high-speed sedimentation to deplete all protein species. Sedimentation equilibrium data were fit by nonlinear least squares curve fitting (using Igor Pro; Wavemetrics, Lake Oswego, OR) to various models that included one, two, or three thermodynamically ideal species in a manner similar to that discussed in Laue (21) . The data were also examined in plots of In(absorbance) vs radial distance squared. In these plots the slope at any point (after correction of nonsedimenting material) is proportional to the weight average molecular weight of the mixture of species present.
The partial specific volume of LBD used was 0.732 ml/gm calculated from the amino acid composition described by Cohn and Edsall (22) . The monomer weight based on sequence is 37,400. The solvent density was 1.0 g/ml. At 280 nm, a solution of LBD of 1 mg/ml (based on Bradford protein assay using BSA as standard) gave an absorbance of 0.41 for a 1-cm path length. This corresponds to an extinction coefficient of 15,000 M Ϫ1 cm Ϫ1 .
Measurement of circular dichroism spectra. Samples of the purified LBD protein were diluted to 0.2 mg/ml in Hepes/NaCl/DTT buffer and the circular dichroism spectra were recorded on an Aviv 62A DS circular dichroism spectrophotometer equipped with a thermoelectric temperature control unit (Aviv Instruments, Lakewood, NJ). Spectra in the far-UV region were recorded in 0.1-cm-path length quartz cuvettes at 25.0°C. The buffer blank was recorded under the same conditions and subtracted from the sample signal. Thermal denaturation was monitored at 207 nm, with temperature scanned from 25 to 85°C in 5°C increments. The signal was recorded immediately upon temperature stabilization as detected by the CD software. CD spectra of the thermally denatured protein were recorded at both 25 and 85°C.
The CD signal of the protein in the near-UV portion of the spectrum (250 to 300 nm) was recorded at 25°C using a protein concentration of 2.0 mg/ml, in a 1-cm-path length masked quartz cuvette. Ligand was added in small aliquots and the contents of the cuvette were mixed by repeated pipetting. Fig. 1 . Following elution from the Ni-NTA column (Fig.  1A) , the protein was judged to be approximately 85% pure. After further purification on the MonoS column, the protein was judged to be greater than 95% pure (Fig. 1B) . The ligand-binding affinity of the purified protein was measured by a modification of the HAPbinding assay and the results are shown in Fig. 2 . The program BIOEQS (see Materials and Methods) was used to fit the data (solid line) and gave a dissociation equilibrium constant, K d , of 0.3 nM.
RESULTS

SDS-PAGE analysis of the purified LBD is shown in
The fluorescence emission spectra of the LBD in absence and presence of 1,25-(OH) 2 D 3 are shown in Fig. 3 . It can be seen that addition of sixfold excess ligand produces a near 90% loss in the tryptophan's emission intensity. Figure 4 shows that a titration of the receptor with ligand produces saturation at a 1:1 complex and that the maximum change in intensity is approximately 90%. 1,25-(OH) 2 D 3 has a nominal absorption at the 295-nm excitation wavelength, and the intensity decrease is maximum at a 1:1 complex (Fig.  4) , which suggests that the intensity loss is not an inner filter effect. There is no significant change in the UV absorption spectrum of LBD after addition of a saturating amount of ligand and adjustment for the ligand's absorption (data not shown), indicating that the decrease in emission intensity is not due to a change in the tryptophan's extinction coefficient.
To determine the nature of the emission decrease the frequency response of the LBD tryptophan (295-nm excitation) was obtained at multiple emission wavelengths (Fig. 5) . Simultaneous analysis of the data at all wavelengths was performed using a triple exponential decay and a linkage scheme in which the three 44 lifetime components across the emission spectrum were considered to be the same in all data sets, while the fractional component to the total intensity (f i ) was allowed to vary across the spectrum. Decay-associated spectra, shown in Fig. 6 , were obtained by multiplying the fractional intensities, f i , for a given component recovered from the analysis for a given emission wavelength by the total steady-state emission intensity at that wavelength. Table I provides a summary of this analysis and illustrates that the three lifetime values recovered from the linked analysis are the same, within error in the absence or in the presence of ligand. The slight change in fractional populations between the 3-and 7-ns values, upon addition of ligand, cannot account for the 90% loss in intensity. Therefore, the addition of ligand produces no significant effects upon the tryptophan's lifetimes or its fractional populations as a function of wavelength, suggesting that the intensity losses are due to static quenching.
The far-UV CD spectrum of native LBD at 25°C is shown in Fig. 7 . The shape of the spectrum shows the characteristic double minima at 220 and 207 nm, consistent with a high content of helical structure, as might be anticipated by comparison with LBDs of related structures. Using the methods of Greenfield and Fasman (23), Chen et al. (24) , and the neural network approach of Andrade et al. (25) , the helical contents of native LBD were estimated as 23.2, 20.0, and 26%, respectively. When saturating amounts of ligand were added, a slight increase in the magnitude of the ellipticity at around 220 nm is observed, which remains to be more fully examined. Thermal denaturation of LBD was found to be irreversible; the spectrum of thermally denatured LBD at 25°C is shown in Fig. 7 . The spectrum at 85°C was similar in shape but somewhat reduced in magnitude. These spectra are quite distinct from that of the native LBD and suggest the loss of helical structure during the denaturation process. Using the predictive schemes mentioned above, the helical content decreased to 11, 10, and 21%, respectively. The temperature for half-maximal loss of signal at 207 nm was dependent on the details of the temperature scan, and was approximately 55°C when the signal was recorded immediately upon temperature equilibration and at 5°C increments.
The CD signal of the protein in the near-UV portion of the spectrum (250 to 300 nm) was also examined. The spectrum of LBD in absence of ligand exhibited a very small signal throughout the range of 250 -300 nm (Fig. 8) , with small positive peaks at approximately 258 and 265 nm. Addition of ligand resulted in major changes in the shape of the spectrum especially near 277 nm, where a large negative peak is established. Ligand itself had a very small signal in this spectral region, negligible up to 280 nm and slightly positive above and negative below this wavelength; the magnitudes of the ligand signal itself would not approach the observed signal at any of the concentrations used in Fig. 8 (data not shown) . Thus, the binding of ligand induces a broad, strong negative peak in the near-UV CD spectrum. The small peaks at 258 and 265 nm appear to remain and to be superimposed on this feature. This increase was saturable at approximately a 1:1 ratio of ligand to protein, indicating that once all available binding sites were occupied, no additional signal was generated by excess ligand.
The state of association of the LBD in solution was examined by sedimentation equilibrium. In fitting data such as in Fig. 9A , we allow the inclusion of a nonsedimenting (baseline) component in addition to the molecular characteristics of the sedimenting species and their interactions. Models that yield baselines substan- trations, individually and globally, to models containing different numbers of species and whether the species were in equilibrium or not. The results have not yielded consistent results across all data sets, as the weights of smallest species present usually came out intermediate between that of the monomer and dimer and with baselines substantially different than the experimentally observed values. When LBD was allowed to reach sedimentation equilibrium and then the speed was reduced to one used earlier in the experiment, we observed that the absorbance at equilibrium at the lower speed at any point in the cell was lower than the original data. This suggests that at the high speed, LBD has formed large aggregates that either do not or only slowly disaggregate. The formation and presence of such aggregates are likely one of the factors complicating the curve fitting of the sedimentation. Thus, we do not at this time have enough information to fully define the molecular species distribution of LBD in solution.
Plots of In(absorbance) vs radial position squared after correcting for the nonsedimenting baselines as in Fig. 9B permit us to gain some insight into the nature of species present in any given sedimentation equilibrium gradient. The slope of the curve at any point is directly proportional to the weight average molecular weight of all species present at that radial position and total concentration (absorbance). The curvature in the plots in Fig. 9B immediately suggests the presence of multiple species of LBD in solution. In these data the curve at low initial protein concentration shows more curvature than does the higher initial concentration. The slope at low values of radial position in the absence of ligand corresponds to weight average molecular weights of 49,900 and 56,600 for the low and high initial concentrations, respectively. Both of these numbers are larger than the monomer molecular weight based on sequence (37,400) and smaller than that expected for the dimer. Since the weights at the highest radial position were 87,800 and 79,100, the presence of species larger than the dimer can be inferred and may include the large aggregates discussed as well as other species. Thus, the data implicate at the least the presence of monomeric LBD and higher oligomers.
The effect of ligand addition upon the oligomeric state of the LBD was also examined. Examples of sedimentation equilibrium data at two different initial concentrations of protein each in the presence and absence of saturating amounts of ligand are shown in Fig. 9 . The difference in curvature of the plots with ligand compared to those in the absence of ligand in Fig. 9B shows that binding of ligand generates a broader range of weight average molecular weights than are seen for the protein alone. At low values of radial position for the low initial protein concentration, the slopes with and without ligand give weight average molecular weights of 51,500 and 49,900, respectively. In both cases the presence of monomer is necessary to explain the observed values, and it seems likely that the same species must be present in both cases. How- Conditions were the same as those described in the legend to Fig. 3. 47 ever, at the higher radial positions, the slope in the presence of ligand gives a molecular weight of 168,000, substantially larger than the molecular weight discussed in the previous paragraph. In the case of the higher initial concentration, the weights at all radial positions are higher in the presence of ligand than in its absence. In the presence of ligand and higher initial protein concentration, low radial positions give a weight of 66,000 and at the highest radial position, 208,000.
DISCUSSION
The ligand-binding affinity of the bacterially expressed LBD reported in this paper falls in the middle of values published for the VDR; the full-length receptor has been reported to have K d values ranging from 0.01 nM (2) to 0.7 nM (26), when the full-length protein was expressed in baculovirus, while the LBD has been expressed in bacteria as a S-glutathione transferase fusion protein (27, 28) with a K d of 0.17 nM. The reason for the variation in K d values is unclear; it may reflect genuine differences in the affinity of the bacterially expressed protein for ligand compared to protein expressed in baculovirus or mammalian cells. Receptor made in bacteria may lack posttranslational modifications which increase the affinity of the protein for ligand. Alternatively, proteins present in eukaryotic cells may be required for the tighter binding observed in these cells (29) . A third possibility is that the variation is due to artifacts in the methodology; for instance, it has been noted for the RXR that the calculated percentage of protein which binds ligand varies widely with the assay used (30) .
Sedimentation equilibrium studies of the LBD demonstrate that LBD exists as a mixture of species in solution, and that the smallest species present must be monomeric. More work is necessary, however, to enumerate what species are present and the molecular mechanism by which they are formed. The presence of multimers of LBD was somewhat surprising given the other receptor LBDs, such as the RAR, have not been reported to self-associate. However, as noted, the LBD of the thyroid hormone receptor was observed to behave as a mixture of monomers and dimers on a gelfiltration column (15) . Although there is one conflicting report (30) , most of the data concerning the RXR LBD supports the formation of dimers, including the crystal structure, gel-filtration chromatography, and dynamic light scattering (11) .
Addition of ligand to LBD dramatically altered the distribution of species detected by sedimentation equi- 49 librium (Fig. 9 ). While the weight average molecular weights observed at low radial positions were similar to the presence and absence of ligand, suggesting a similar mixture of species including monomer, at higher radial position (protein concentration), the apparent molecular weights in the presence of ligand were substantially higher than in the absence. This suggests that binding of ligand causes the formation of higher oligomeric states not present in the absence of ligand, or at least a shift toward higher oligomers. Alternatively, binding of ligand may limit the irreversible formation of large aggregates inferred from the work with LBD alone and result in a new distribution of species. More work is needed to define and quantitate the number of species present and their interrelationships. The physiological significance of multimer formation for the LBD of the VDR is unclear. These data may reflect relatively nonspecific interactions between LBD monomers at the protein concentrations used, perhaps due to hydrophobic interactions between nonpolar amino acids in the ligand-binding site of the protein. In the absence of ligand, such interactions could account for the presence of large irreversible aggregates inferred from the sedimentation equilibrium studies. It has been noted previously that addition of ligand to the thyroid hormone receptor decreased the hydrophobicity of the protein (14) . If the VDR LBD behaves in a similar fashion upon binding of ligand, this would decrease the extent of these hydrophobic interactions, limiting the formation of very large irreversible aggregates and shift the observed distribution to smaller oligomers but still larger than those seen in the absence of ligand. The addition of ligand to VDR has been shown to enhance its ability to heterodimerize with RXR on a response element (31, 32) , and the shift among oligomeric states in LBD in response to ligand binding may reflect these interactions. However, it is possible that multimer formation by the LBD occurs through a different region of the protein than that which is involved in heterodimer formation with RXR. Alternatively, the truncated protein may act in a different manner in solution from the full-length protein, due to the absence of regions in the DNA-binding do- Further information on these interactions will be best gathered using full-length versions of the receptor.
One of the interesting implications of the work reported here concerns the ligand-binding conformation change of the LBD. This model of conformational change was proposed by Renaud et al. (6) for the RAR. The LBD of RXR (without ligand) and the RAR (with ligand) were observed to have similar secondary structures but ligand had caused the carboxy-terminal helices 11 and 12 of RAR to move over the bound retinoid in what the authors termed a "mouse-trap" mechanism. This change in structure may help to explain the biophysical changes observed upon ligand binding to a receptor. In the RAR and RXR, retinoid binding was accompanied by loss of greater than 90% of the tryptophan fluorescence signal (10, 11) . This may result from trapping of the bound retinoid in close proximity to one or more tryptophan residues in the binding pocket. The relevance of these observations to the VDR is highlighted by sequence comparison. The amino acid sequences of the LBDs of the RAR, thyroid hormone receptor, and VDR were aligned using the program Pileup (Genetics Computer Group, University of Wisconsin-Madison). The solved structures of the TR and RAR showed a high degree of alignment of secondary structural elements and amino acids in contact with bound ligand (Fig. 10) . The LBD of the VDR showed significant sequence matchup with the other receptors as shown by the alignment of identical residues between all three proteins. From this alignment, it can be extrapolated that the tryptophan residue in the VDR may be in a region of ␤-sheet (Fig. 10) . This VDR tryptophan is in a sequence which in the RAR and TR contains residues in proximity to bound ligand (phenylalanine 288 in RAR and leucine 276 in TR). Our data shows that binding of 1,25-(OH) 2 D 3 to the VDR resulted in tryptophan quenching of the same magnitude and mechanism as in the RXR and RAR, which suggests that the ligand and tryptophan may also be in close proximity in the VDR. This argument is supported by the near-UV CD spectrum (250 -300 nm), which shows dramatic increases in signal upon addition of ligand. This CD signal arises from interactions of aromatic residue with their electronic environments, i.e., the details of the tertiary structure in vicinity of the residue (13) . The increase in signal upon binding of ligand results from a significant change in the structure surrounding one or more aromatic residues. The major aromatic residue in this case could well be the Helices are denoted by numbers in accordance with the TR structure; sheet regions are denoted s1-s4, also according to the TR structure. Amino acids in the RAR and TR shown by X-ray crystallography to be in contact with ligand are shaded.
